Cyanotech (NASDAQ:CYAN) announced its quarterly earnings data on Tuesday. The biotechnology company reported $0.19 earnings per share (EPS) for the quarter, Bloomberg Earnings reports. The business had revenue of $9.15 million during the quarter. Cyanotech had a net margin of 5.44% and a return on equity of 10.51%.
Cyanotech (NASDAQ CYAN) traded down $0.20 during trading on Thursday, hitting $5.15. 2,293 shares of the stock traded hands, compared to its average volume of 12,258. The company has a quick ratio of 0.72, a current ratio of 2.36 and a debt-to-equity ratio of 0.33. Cyanotech has a 1 year low of $3.25 and a 1 year high of $5.78. The company has a market capitalization of $30.20, a P/E ratio of 17.13 and a beta of 0.99.
Separately, ValuEngine downgraded shares of Cyanotech from a “hold” rating to a “sell” rating in a research note on Friday, November 10th.
ILLEGAL ACTIVITY NOTICE: This article was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://sportsperspectives.com/2018/02/08/cyanotech-cyan-issues-quarterly-earnings-results.html.
Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.
Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.